Home
>
National Drug Code (NDC)
>
Invirase
Invirase - 0004-0245-15 - (saquinavir mesylate)
Drug Information of Invirase
| Product NDC: | 0004-0245 |
| Proprietary Name: | Invirase |
| Non Proprietary Name: | saquinavir mesylate |
| Active Ingredient(s): | 200 mg/1 & nbsp; saquinavir mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Invirase
| Product NDC: | 0004-0245 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020628 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19951206 |
Package Information of Invirase
| Package NDC: | 0004-0245-15 |
| Package Description: | 270 CAPSULE in 1 BOTTLE, PLASTIC (0004-0245-15) |
NDC Information of Invirase
| NDC Code | 0004-0245-15 |
| Proprietary Name | Invirase |
| Package Description | 270 CAPSULE in 1 BOTTLE, PLASTIC (0004-0245-15) |
| Product NDC | 0004-0245 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | saquinavir mesylate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19951206 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | SAQUINAVIR MESYLATE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] |
